These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28289407)

  • 21. The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage.
    Sisakhtpour B; Mirzaei A; Karbasizadeh V; Hosseini N; Shabani M; Moghim S
    Ann Clin Microbiol Antimicrob; 2022 Jan; 21(1):1. PubMed ID: 34996464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
    Kim S; Jin JS; Choi YJ; Kim J
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of endolysin from a Salmonella Typhimurium-infecting bacteriophage SPN1S.
    Lim JA; Shin H; Kang DH; Ryu S
    Res Microbiol; 2012 Apr; 163(3):233-41. PubMed ID: 22289622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa.
    Briers Y; Walmagh M; Lavigne R
    J Appl Microbiol; 2011 Mar; 110(3):778-85. PubMed ID: 21241420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
    Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
    Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria.
    Khan FM; Rasheed F; Yang Y; Liu B; Zhang R
    Front Pharmacol; 2024; 15():1385261. PubMed ID: 38831886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial and Anti-Biofilm Efficacy of Endolysin LysAB1245 against a Panel of Important Pathogens.
    Soontarach R; Srimanote P; Voravuthikunchai SP; Chusri S
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Chimeric Endolysin Conjugated Chitosan Nanocomplex as a Potential Inhibitor Against Gram-Positive and Gram-Negative Bacteria.
    Abbasi P; Fahimi H; Khaleghi S
    Appl Biochem Biotechnol; 2024 Jan; 196(1):478-490. PubMed ID: 37140784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Phage Lysin Abp013 against
    Chu JJK; Poh WH; Hasnuddin NTB; Hew EY; Dam LC; Sahili AE; Rice SA; Goh BC
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Lysozyme Murein Hydrolase with Broad-Spectrum Antibacterial Activity from Enterobacter Phage myPSH1140.
    Ramesh N; Manohar P; Eniyan K; Archana L; Athira S; Loh B; Ma L; Leptihn S
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0050622. PubMed ID: 35950843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends and patterns in antimicrobial-resistant Gram-negative bacteria implicated in intensive care unit-acquired infections: A cohort-based surveillance study in Istanbul, Turkey.
    Durdu B; Kritsotakis EI; Lee ACK; Torun P; Hakyemez IN; Gultepe B; Aslan T
    J Glob Antimicrob Resist; 2018 Sep; 14():190-196. PubMed ID: 29751127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.
    Mende K; Akers KS; Tyner SD; Bennett JW; Simons MP; Blyth DM; Li P; Stewart L; Tribble DR
    Mil Med; 2022 May; 187(Suppl 2):42-51. PubMed ID: 35512375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Endolysin LysECP26 Derived from rV5-like Phage vB_EcoM-ECP26 for Inactivation of
    Park DW; Park JH
    J Microbiol Biotechnol; 2020 Oct; 30(10):1552-1558. PubMed ID: 32699198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids.
    Yan G; Yang R; Fan K; Dong H; Gao C; Wang S; Yu L; Cheng Z; Lei L
    AMB Express; 2019 Jul; 9(1):106. PubMed ID: 31309363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
    Lim JA; Shin H; Heu S; Ryu S
    J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against
    Wu M; Hu K; Xie Y; Liu Y; Mu D; Guo H; Zhang Z; Zhang Y; Chang D; Shi Y
    Front Microbiol; 2018; 9():3302. PubMed ID: 30687281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.